Biotech Acquisition Company announced that it has issued an unsecured promissory note in the principal amount of $250,000 on October 4, 2022. The transaction will include participation from Biotech Sponsor LLC. The sponsor note bears no interest.

The principal balance of the sponsor note shall be due and payable in accordance with its terms on or before September 30, 2023, or the date on which Maker consummates an initial business combination, including without limitation a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Maker and one or more businesses.